All cases were either confirmed carriers or obligate carriers of likely pathogenic or pathogenic germline variant in STK11 (Table 1).There were 34 breast cancers in 27 patients (including five bilateral synchronous tumors, one case with bilateral metachronous tumors, and one metachronous unilateral tumor). Here, STK11 is linked to neoplasm.